| NCT ID | NCT05531773 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Euresist Network GEIE |
| Condition | COVID-19 |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,300 participants |
| Start Date | 2022-07-01 |
| Primary Completion | 2025-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,300 participants in total. It began in 2022-07-01 with a primary completion date of 2025-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The EuCARE-POSTCOVID study is an observational multicentre study enrolling COVID-19 patients recovered from the acute phase of disease to investigate the prevalence and possible predictors of post COVID-19 condition. The study will retrospectively analyze data already collected at the post COVID-19 outpatients services of the participating centers; furthermore, a prospective cohort study will be performed.
Eligibility Criteria
Inclusion Criteria: * Adult patients, \>18 years old; * Confirmed diagnosis of COVID-19 disease (positive SARS CoV-2 RNA on naso- pharyngeal swab or upper respiratory sample); * Mild COVID-19 disease without hospital admission or moderate/severe disease requiring hospital admission for COVID-19 or hospitalization for other medical issues with a positive SARS CoV-2 RNA sample; * Informed consent for the study. Exclusion Criteria: * death during hospitalization: * patient's decline to participate in the study.
Contact & Investigator
ANTONELLA D'ARMINIO MONFORTE, PROF
STUDY CHAIR
ASST SANTI GIOVANNI E CARLO
Frequently Asked Questions
Who can join the NCT05531773 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying COVID-19. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05531773 currently recruiting?
Yes, NCT05531773 is actively recruiting participants. Contact the research team at francesca.incardona@euresist.org for enrollment information.
Where is the NCT05531773 trial being conducted?
This trial is being conducted at Düsseldorf, Germany, Rome, Italy, Milan, Italy, Vilnius, Lithuania and 3 additional locations.
Who is sponsoring the NCT05531773 clinical trial?
NCT05531773 is sponsored by Euresist Network GEIE. The principal investigator is ANTONELLA D'ARMINIO MONFORTE, PROF at ASST SANTI GIOVANNI E CARLO. The trial plans to enroll 2,300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.